Treatment with the immunotherapy dostarlimab showed promising results in a small trial of a dozen rectal cancer patients, according to new research, but further study is needed and it is too early to call it a cure. CNN's Erin Burnett speaks to Dr. Andrea Cercek, an oncologist at Memorial Sloan Kettering Cancer Center.
تقديرا لمجهود صاحب البوست او المشاركه فانه لا يمكن مشاهدة الروابط إلا بعد التعليق على البوست In appreciation of the efforts of the owner of the post or participation, the links cannot be viewed until after responding to the post or participation
تقديرا لمجهود صاحب البوست او المشاركه فانه لا يمكن مشاهدة الروابط إلا بعد التعليق على البوست In appreciation of the efforts of the owner of the post or participation, the links cannot be viewed until after responding to the post or participation
تقديرا لمجهود صاحب البوست او المشاركه فانه لا يمكن مشاهدة الروابط إلا بعد التعليق على البوست In appreciation of the efforts of the owner of the post or participation, the links cannot be viewed until after responding to the post or participation
تقديرا لمجهود صاحب البوست او المشاركه فانه لا يمكن مشاهدة الروابط إلا بعد التعليق على البوست In appreciation of the efforts of the owner of the post or participation, the links cannot be viewed until after responding to the post or participation
تقديرا لمجهود صاحب البوست او المشاركه فانه لا يمكن مشاهدة الروابط إلا بعد التعليق على البوست In appreciation of the efforts of the owner of the post or participation, the links cannot be viewed until after responding to the post or participation